CN116589515B - Preparation method of p-propenylphenol glycoside with whitening effect - Google Patents
Preparation method of p-propenylphenol glycoside with whitening effect Download PDFInfo
- Publication number
- CN116589515B CN116589515B CN202310888639.7A CN202310888639A CN116589515B CN 116589515 B CN116589515 B CN 116589515B CN 202310888639 A CN202310888639 A CN 202310888639A CN 116589515 B CN116589515 B CN 116589515B
- Authority
- CN
- China
- Prior art keywords
- methanol
- preparation
- glycoside
- phase
- propenylphenol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 p-propenylphenol glycoside Chemical class 0.000 title claims abstract description 35
- 229930182470 glycoside Natural products 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 230000002087 whitening effect Effects 0.000 title claims abstract description 14
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 29
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 29
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 22
- 241000212314 Foeniculum Species 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 239000012071 phase Substances 0.000 claims description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 18
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000741 silica gel Substances 0.000 claims description 14
- 229910002027 silica gel Inorganic materials 0.000 claims description 14
- 239000003208 petroleum Substances 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 235000007129 Cuminum cyminum Nutrition 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000000287 crude extract Substances 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 238000010898 silica gel chromatography Methods 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 6
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000012267 brine Substances 0.000 claims description 2
- JJBKVCQUFIBRFK-UHFFFAOYSA-N chloromethane;methanol Chemical compound OC.ClC JJBKVCQUFIBRFK-UHFFFAOYSA-N 0.000 claims description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 2
- 244000304337 Cuminum cyminum Species 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 238000002390 rotary evaporation Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 17
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 15
- 229960004441 tyrosine Drugs 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 9
- 241000510672 Cuminum Species 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 239000012085 test solution Substances 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229930015704 phenylpropanoid Natural products 0.000 description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 125000001474 phenylpropanoid group Chemical group 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 3
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 150000008505 β-D-glucopyranosides Chemical class 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域Technical field
本发明属于生物医药技术领域,具体涉及具有美白作用的对丙烯基苯酚糖苷的制备方法。The invention belongs to the technical field of biomedicine, and specifically relates to a preparation method of p-propenylphenol glycoside with whitening effect.
背景技术Background technique
皮肤是人体最大的器官,人们通常使用护肤品为皮肤创造一个良好的局部环境,以有利于皮肤的生存和生长,从而达到抗衰老、抗皱纹和保湿祛痘的功效。皮肤的白净程度与黑色素有极大的关系,黑色素由黑色素细胞产生后向角质细胞、表皮细胞和角质层转移,最后随角质层的脱落而排泄,以此影响皮肤的颜色或形成色斑。酪氨酸酶(TYR)是人体调控黑色素生成的限速酶,酪氨酸酶仅由黑色素细胞产生,且黑色素合成量与酪氨酸酶的活性相关,可通过调控细胞中酪氨酸酶的表达量来有效调控黑色素的生成,从而达到肌肤美白的效果,因此,基于抑制酪氨酸酶活性的黑色素生物合成抑制剂成为了研究领域的热点,通过与酪氨酸酶活性中心结合而开发化合物抑制剂是其中关注度较高的一类。Skin is the largest organ of the human body. People usually use skin care products to create a good local environment for the skin, which is conducive to the survival and growth of the skin, thereby achieving the effects of anti-aging, anti-wrinkles, moisturizing and acne removal. The whiteness of the skin is closely related to melanin. Melanin is produced by melanocytes and then transferred to keratinocytes, epidermal cells and stratum corneum. Finally, it is excreted with the shedding of the stratum corneum, thereby affecting the color of the skin or forming stains. Tyrosinase (TYR) is the rate-limiting enzyme in the human body that regulates melanin production. Tyrosinase is only produced by melanocytes, and the amount of melanin synthesis is related to the activity of tyrosinase. It can be regulated by regulating the activity of tyrosinase in cells. The expression level can effectively regulate the production of melanin, thereby achieving the effect of skin whitening. Therefore, melanin biosynthesis inhibitors based on inhibiting tyrosinase activity have become a hot spot in the research field. Compounds are developed by combining with the tyrosinase active center. Inhibitors are one of the more interesting categories.
小茴香为伞形科植物茴香Foeniculum vulgareMill.的干燥成熟果实,其原名蘹香,其药用历史悠久,始载于《唐本草》,有一千多年药用历史。除药用外,小茴香还是常用的食品香料,故为药食两用之佳品。小茴香分布广泛,主要分布于地中海地区,我国主要分布于西北地区的山西、甘肃、内蒙古,以及东北地区的辽宁等地区,其资源丰富,以栽培为主,栽培面积广泛,其中以山西产量最大、内蒙古河套附近产品质优。Fennel is the dried and mature fruit of Foeniculum vulgare Mill., an Umbelliferae plant. Its original name is Xiangxiang. Its medicinal history is long. It was first recorded in "Tang Materia Medica" and has a medicinal history of more than a thousand years. In addition to its medicinal uses, cumin is also a commonly used food spice, so it is a good product for both medicinal and food purposes. Fennel is widely distributed, mainly in the Mediterranean region. In my country, it is mainly distributed in Shanxi, Gansu, Inner Mongolia in the northwest, and Liaoning in the northeast. It is rich in resources and is mainly cultivated with a wide cultivation area. Shanxi has the largest output. , high-quality products near Hetao, Inner Mongolia.
小茴香主要含有挥发油,以及苯丙素、黄酮、糖苷、脂肪油、酚酸等类型的化合物,目前研究开发主要集中于挥发油,且以成分分析为主,对化合物分离纯化及鉴定报道不多,其富含的非挥发性成分,如苯丙素苷类缺乏深入研究开发,本发明发现,部分苯丙素具有良好的抑制酪氨酸酶活性的作用,提示小茴香中的苯丙素可能具有较良好的美白作用。Fennel mainly contains volatile oil, as well as phenylpropanoids, flavonoids, glycosides, fatty oils, phenolic acids and other types of compounds. Current research and development mainly focuses on volatile oil, and is mainly based on component analysis. There are not many reports on the separation, purification and identification of compounds. Its rich non-volatile components, such as phenylpropanoid glycosides, lack in-depth research and development. The present invention found that some phenylpropanoids have a good effect on inhibiting tyrosinase activity, suggesting that the phenylpropanoids in fennel may have Better whitening effect.
发明内容Contents of the invention
本发明的目的在于提供具有美白作用的对丙烯基苯酚糖苷的制备方法。The object of the present invention is to provide a preparation method of p-propenylphenol glycoside with whitening effect.
本发明的目的是这样实现的:The purpose of the present invention is achieved as follows:
对丙烯基苯酚糖苷的结构式为,其制备方法为:The structural formula of p-propenylphenol glycoside is , its preparation method is:
(1)乙醇提取:小茴香样品20 kg粉碎过10目筛,在10 L的体积浓度为75%乙醇中回流提取,每次10L,每次2小时,提取5次;合并得提取液,通过旋转蒸发仪减压除去溶剂得到2.387 kg粗提物A;(1) Ethanol extraction: 20 kg of cumin sample was crushed through a 10-mesh sieve, and extracted in 10 L of 75% ethanol with reflux, 10 L each time, 2 hours each time, and extracted 5 times; the extracts were combined and passed The solvent was removed under reduced pressure on a rotary evaporator to obtain 2.387 kg of crude extract A;
(2)萃取分离:将粗提物A加水混悬,使用石油醚、乙酸乙酯、正丁醇依次分别萃取五次,合并萃取液,减压浓缩得到石油醚相、乙酸乙酯相B正丁醇相和水相;(2) Extraction and separation: Suspend the crude extract A with water, extract five times with petroleum ether, ethyl acetate, and n-butanol in sequence, combine the extracts, and concentrate under reduced pressure to obtain the petroleum ether phase and the ethyl acetate phase B. Butanol phase and water phase;
(3)分离精制:乙酸乙酯相B经200-300目正向硅胶色谱,以二氯甲烷-甲醇梯度洗脱,二氯甲烷-甲醇的体积比为100:1-1:1,馏分经正向硅胶板以石油醚-乙酸乙酯1:1为展开剂展开,合并Rf值在0.3~0.8之间的馏分Fr.7,Fr.7经100-200目正向硅胶色谱,以二氯甲烷-甲醇梯度洗脱,二氯甲烷-甲醇的体积比为50:1-1:1,馏分经正向硅胶板以二氯甲烷-甲醇10:1为展开剂展开,合并Rf值在0.1~0.6之间的馏分Fr.7.6,Fr.7.6经反相 ODS 柱色谱,以甲醇-水梯度洗脱,甲醇-水的体积比为20∶80~100∶0,馏分经正向硅胶板以二氯甲烷-甲醇10:1加2滴甲酸为展开剂展开,合并Rf值在0.3~0.4之间的馏分Fr.7.6.2,Fr.7.6.2经Sephadex LH-20 色谱分离,色谱条件为:甲醇,高度:1.5米,流速:4秒每滴;再以半制备液相纯化,色谱条件为乙腈-水15∶85;体积流量3 ml/min;检测波长:365 nm纯化得化合物4-(1E)-1-丙烯-1-基苯基β-D-吡喃葡萄糖苷[trans-4-(1-propenyl)-phenol-β-D-glucopyranoside],即对丙烯基苯酚糖苷。(3) Separation and purification: ethyl acetate phase B is subjected to 200-300 mesh forward silica gel chromatography, and is eluted with a dichloromethane-methanol gradient. The volume ratio of dichloromethane-methanol is 100:1-1:1, and the fraction is The forward silica gel plate was developed with petroleum ether-ethyl acetate 1:1 as the developing agent. The fractions Fr.7 with R f value between 0.3 and 0.8 were combined. Fr.7 was subjected to forward silica gel chromatography with 100-200 mesh. Methyl chloride-methanol gradient elution, the volume ratio of dichloromethane-methanol is 50:1-1:1, the fractions are developed through the forward silica gel plate with dichloromethane-methanol 10:1 as the developing agent, and the combined R f value is at The fractions Fr.7.6 and Fr.7.6 between 0.1~0.6 were subjected to reversed-phase ODS column chromatography and eluted with a methanol-water gradient. The volume ratio of methanol-water was 20:80~100:0. The fractions were passed through a forward silica gel plate. Use dichloromethane-methanol 10:1 plus 2 drops of formic acid as a developing agent. Combine the fractions Fr.7.6.2 with R f value between 0.3 and 0.4. Fr.7.6.2 is separated by Sephadex LH-20 chromatography. Chromatography The conditions are: methanol, height: 1.5 meters, flow rate: 4 seconds per drop; then purified by semi-preparative liquid phase, chromatographic conditions are acetonitrile-water 15:85; volume flow rate: 3 ml/min; detection wavelength: 365 nm, the purified compound is obtained 4-(1 E )-1-propen-1-ylphenyl β - D -glucopyranoside [trans-4-(1-propenyl)-phenol- β - D -glucopyranoside], p-propenylphenol glycoside .
所述小茴香为盐炙小茴香。The fennel is salt-roasted fennel.
所述盐炙小茴香的制备:取小茴香,每公斤小茴香加100ml盐水,密封,闷透30min,置炒制容器内,文火加热,温度为110-120℃,炒至微黄时,取出,放凉,备用。Preparation of the salt-roasted fennel: take fennel, add 100ml of salt water per kilogram of fennel, seal it, suffocate it for 30 minutes, place it in a frying container, heat it over a slow fire to a temperature of 110-120°C, fry it until it is slightly yellow, and take it out , let cool and set aside.
所述盐水为饱和食盐水。The brine is saturated salt water.
用该制备方法得到的对丙烯基苯酚糖苷在制备酪氨酸酶抑制剂产品中的应用。Application of p-propenylphenol glycoside obtained by this preparation method in preparing tyrosinase inhibitor products.
一种美白产品,包含上述制备方法得到的对丙烯基苯酚糖苷。A whitening product containing p-propenylphenol glycoside obtained by the above preparation method.
本发明优点:Advantages of the invention:
本发明的优点和积极效果在于,开发了一种新的对丙烯基苯酚糖苷的制备方法。The advantage and positive effect of the present invention is that a new preparation method of p-propenylphenol glycoside is developed.
本发明的制备方法得到的对丙烯基苯酚糖苷具有酪氨酸酶抑制作用,可用于美白产品。The p-propenylphenol glycoside obtained by the preparation method of the present invention has tyrosinase inhibitory effect and can be used in whitening products.
附图说明Description of drawings
图1为对丙烯基苯酚糖苷的化学结构。Figure 1 shows the chemical structure of p-propenylphenol glycoside.
图2为对丙烯基苯酚糖苷的1H-NMR谱。Figure 2 is the 1 H-NMR spectrum of p-propenylphenol glycoside.
图3为对丙烯基苯酚糖苷的13C-NMR(DEPT)谱。Figure 3 is the 13 C-NMR (DEPT) spectrum of p-propenylphenol glycoside.
图4为β-熊果苷对酪氨酸酶的浓度抑制曲线。Figure 4 is the concentration inhibition curve of β -arbutin on tyrosinase.
图5为对丙烯基苯酚糖苷对酪氨酸酶的浓度抑制曲线。Figure 5 is the concentration inhibition curve of p-propenylphenol glycoside on tyrosinase.
具体实施方式Detailed ways
本发明提供了具有美白作用的对丙烯基苯酚糖苷的制备方法。The invention provides a preparation method of p-propenylphenol glycoside with whitening effect.
对丙烯基苯酚糖苷的结构式为,其制备方法为:The structural formula of p-propenylphenol glycoside is , its preparation method is:
(1)乙醇提取:盐炙小茴香样品20 kg粉碎过10目筛,在10 L的体积浓度为75%乙醇中回流提取,每次10L,每次2小时,提取5次;合并得提取液,通过旋转蒸发仪减压除去溶剂得到2.387 kg粗提物A;(1) Ethanol extraction: 20 kg of salt-roasted cumin sample was crushed and passed through a 10-mesh sieve, and extracted in 10 L of 75% ethanol with reflux, 10 L each time, 2 hours each time, and extracted 5 times; the extracts were combined , the solvent was removed under reduced pressure using a rotary evaporator to obtain 2.387 kg of crude extract A;
(2)萃取分离:将粗提物A加水混悬,使用石油醚、乙酸乙酯、正丁醇依次分别萃取五次,合并萃取液,减压浓缩得到石油醚相、乙酸乙酯相B正丁醇相和水相;(2) Extraction and separation: Suspend the crude extract A with water, extract five times with petroleum ether, ethyl acetate, and n-butanol in sequence, combine the extracts, and concentrate under reduced pressure to obtain the petroleum ether phase and the ethyl acetate phase B. Butanol phase and water phase;
(3)分离精制:乙酸乙酯相B经200-300目正向硅胶色谱,以二氯甲烷-甲醇(100:1-1:1)梯度洗脱,馏分经正向硅胶板以石油醚-乙酸乙酯1:1为展开剂展开,合并Rf值在0.3~0.8之间的馏分Fr.7,Fr.7经100-200目正向硅胶色谱,以二氯甲烷-甲醇(50:1-1:1)梯度洗脱,馏分经正向硅胶板以二氯甲烷-甲醇10:1为展开剂展开,合并Rf值在0.1~0.6之间的馏分Fr.7.6,Fr.7.6经反相 ODS 柱色谱,以甲醇-水(20∶80~100∶0)梯度洗脱,馏分经正向硅胶板以二氯甲烷-甲醇10:1加2滴甲酸为展开剂展开,合并Rf值在0.3~0.4之间的馏分Fr.7.6.2,Fr.7.6.2经Sephadex LH-20 色谱分离,色谱条件为:甲醇,高度:1.5米,流速:4秒每滴;再以半制备液相纯化,色谱条件为乙腈-水15∶85;体积流量3 ml/min;检测波长:365 nm纯化得化合物4-(1E)-1-丙烯-1-基苯基β-D-吡喃葡萄糖苷[trans-4-(1-propenyl)-phenol-β-D-glucopyranoside],即对丙烯基苯酚糖苷。(3) Separation and purification: ethyl acetate phase B is subjected to 200-300 mesh forward silica gel chromatography, eluting with dichloromethane-methanol (100:1-1:1) gradient, and the fraction is passed through a forward silica gel plate and eluted with petroleum ether- Develop with ethyl acetate 1:1 as the developing solvent, combine fraction Fr.7 with R f value between 0.3 and 0.8, Fr.7 is subjected to 100-200 mesh forward silica gel chromatography, and dichloromethane-methanol (50:1 -1:1) gradient elution, the fractions were developed through the forward silica gel plate using dichloromethane-methanol 10:1 as the developing agent, and the fractions Fr.7.6 with R f value between 0.1 and 0.6 were combined. Phase ODS column chromatography, using methanol-water (20:80~100:0) gradient elution, the fractions were developed on a forward silica gel plate using dichloromethane-methanol 10:1 plus 2 drops of formic acid as a developing agent, and the R f values were combined Fractions Fr.7.6.2 and Fr.7.6.2 between 0.3~0.4 were separated by Sephadex LH-20 chromatography. The chromatographic conditions were: methanol, height: 1.5 meters, flow rate: 4 seconds per drop; then use half of the preparation solution Phase purification, chromatographic conditions are acetonitrile-water 15:85; volume flow 3 ml/min; detection wavelength: 365 nm, purified compound 4-(1 E )-1-propen-1-ylphenyl β - D -pyran Glucoside [trans-4-(1-propenyl)-phenol- β - D -glucopyranoside] is p-propenylphenol glycoside.
小茴香为盐炙小茴香。Cumin is salt-roasted fennel.
盐炙小茴香的制备:取小茴香,每公斤小茴香加100ml盐水,密封,闷透30min,置炒制容器内,文火加热,温度为110-120℃,炒至微黄时,取出,放凉,备用。Preparation of salt-roasted fennel: Take fennel, add 100ml salt water per kilogram of fennel, seal it, simmer it for 30 minutes, place it in a frying container, heat it over a slow fire to a temperature of 110-120°C, stir-fry until it is slightly yellow, take it out and put it away Cool and set aside.
盐水为饱和食盐水。Salt water is saturated salt water.
用该制备方法得到的对丙烯基苯酚糖苷在制备酪氨酸酶抑制剂产品中的应用。Application of p-propenylphenol glycoside obtained by this preparation method in preparing tyrosinase inhibitor products.
一种美白产品,包含由上述制备方法得到的对丙烯基苯酚糖苷。A whitening product containing p-propenylphenol glycoside obtained by the above preparation method.
下面对本发明作进一步的说明,但不以任何方式对本发明加以限制,基于本发明所作的任何变换,均属于本发明的保护范围。The present invention will be further described below, but the present invention will not be limited in any way. Any transformation made based on the present invention shall fall within the protection scope of the present invention.
实施例1Example 1
盐炙小茴香的制备Preparation of salt-roasted cumin
取食盐,加水,制成饱和溶液,即为盐水。Take salt and add water to make a saturated solution, which is salt water.
取小茴香20kg,加2000ml盐水,密封,闷透30min,置炒制容器内,文火加热(110-120℃),炒至微黄时,取出,放凉,备用。Take 20kg of cumin, add 2000ml of salt water, seal, simmer for 30 minutes, place in a frying container, heat over low heat (110-120℃), fry until slightly yellow, take out, let cool, and set aside.
实施例2Example 2
对丙烯基苯酚糖苷的制备方法Preparation method of p-propenylphenol glycoside
1.1材料1.1 Materials
色谱硅胶(100~200目,200~300目,青岛海洋化工厂);GF254薄层色谱硅胶(青岛海洋化工厂);LH-20羟丙基葡聚糖凝胶(美国Pharmacia公司);反相C18柱色谱材料(ODS,德国Merck公司);薄层色谱显色剂(10% 硫酸乙醇溶液);甲醇、乙醇、丙酮、正丁醇、乙酸乙酯、二氯甲烷、石油醚等试剂为重蒸的工业或化学纯溶剂;色谱乙腈(上海星可高纯溶剂有限公司)。Chromatography silica gel (100~200 mesh, 200~300 mesh, Qingdao Ocean Chemical Factory); GF254 thin layer chromatography silica gel (Qingdao Ocean Chemical Factory); LH-20 hydroxypropyl dextran gel (Pharmacia, USA); reversed phase C18 column chromatography material (ODS, Merck Company of Germany); thin layer chromatography developer (10% sulfuric acid ethanol solution); reagents such as methanol, ethanol, acetone, n-butanol, ethyl acetate, methylene chloride, petroleum ether and other reagents are heavy Steamed industrial or chemically pure solvent; chromatographic acetonitrile (Shanghai Xingke High Purity Solvent Co., Ltd.).
小茴香药材于2022年9月购自新螺蛳湾药材市场,由云南中医药大学李宏哲副教授鉴定为伞形科植物茴香Foeniculum vulgareMill.的干燥成熟果实。Fennel medicinal materials were purchased from the Xinluosi Bay medicinal materials market in September 2022. Associate Professor Li Hongzhe of Yunnan University of Traditional Chinese Medicine identified them as the dried and mature fruits of Foeniculum vulgare Mill., an Umbelliferae plant.
1.2仪器1.2 Instruments
Bruker Avance III 400 MHz及Bruker DRX 500 MHz超导核磁共振仪,TMS为内标(德国Bruker公司);高效液相色谱仪Agilent 1200型(美国Agilent公司);离子井飞行时间质谱仪Esquire HCT型(德国Bruker公司);万分之一分析天平FA2004(上海舜宇恒平科学仪器有限公司);循环水式多用真空泵 SHB-Ⅲ(巩义市予华仪器有限公司);海道夫旋转蒸发仪Hei-VAP Core HL/G(德国heidolph)。Bruker Avance III 400 MHz and Bruker DRX 500 MHz superconducting nuclear magnetic resonance instrument, TMS as internal standard (Bruker Company, Germany); high performance liquid chromatograph Agilent 1200 type (Agilent Company, USA); ion well time-of-flight mass spectrometer Esquire HCT type ( Bruker Company, Germany); One-tenthousandth analytical balance FA2004 (Shanghai Sunny Hengping Scientific Instrument Co., Ltd.); Circulating water multi-purpose vacuum pump SHB-Ⅲ (Gongyi Yuhua Instrument Co., Ltd.); Heidorf rotary evaporator Hei-VAP Core HL/G (German Heidolph).
2 提取分离过程2 Extraction and separation process
盐炙小茴香样品20 kg粉碎过10目筛,在10 L的75%乙醇中回流提取,每次10L,每次2小时,提取5次。合并得提取液,通过旋转蒸发仪减压除去溶剂得到2.387 kg粗提物,粗提物加水混悬并使用石油醚、乙酸乙酯、正丁醇依次分别萃取五次,合并萃取液,减压浓缩得到石油醚相203.6g、乙酸乙酯相73.9 g、正丁醇相316.7 g和水相759.3 g。乙酸乙酯部位经正向硅胶色谱(200-300目),以二氯甲烷-甲醇(100:1-1:1)梯度洗脱,馏分经正向硅胶板以石油醚-乙酸乙酯1:1为展开剂展开,合并Rf值在0.3~0.8之间的馏分Fr.7,Fr.7经正向硅胶色谱(100-200目),以二氯甲烷-甲醇(50:1-1:1)梯度洗脱,馏分经正向硅胶板以二氯甲烷-甲醇10:1为展开剂展开,合并Rf值在0.1~0.6之间的馏分Fr.7.6,Fr.7.6经反相 ODS 柱色谱,以甲醇-水(20∶80~100∶0)梯度洗脱,馏分经正向硅胶板以二氯甲烷-甲醇10:1加2滴甲酸为展开剂展开,合并Rf值在0.3~0.4之间的馏分Fr.7.6.2,Fr.7.6.2经Sephadex LH-20色谱(甲醇,高度:1.5米,流速:4秒每滴)分离,再以半制备液相纯化(乙腈-水15∶85;体积流量3 ml/min;检测波长:365 nm),纯化得化合物4-(1E)-1-丙烯-1-基苯基β-D-吡喃葡萄糖苷[trans-4-(1-propenyl)-phenol-β-D-glucopyranoside(9.9 mg)],即对丙烯基苯酚糖苷,该化合物的化学结构见图1,图2为对丙烯基苯酚糖苷的1H-NMR谱。图3为对丙烯基苯酚糖苷的13C-NMR(DEPT)谱。20 kg of salt-roasted cumin sample was crushed and passed through a 10-mesh sieve, and then refluxed and extracted in 10 L of 75% ethanol, 10 L each time, 2 hours each time, and extracted 5 times. The extracts were combined, and the solvent was removed under reduced pressure using a rotary evaporator to obtain 2.387 kg of crude extract. The crude extract was suspended in water and extracted five times with petroleum ether, ethyl acetate, and n-butanol in sequence. The extracts were combined and the pressure was reduced. Concentrate to obtain 203.6 g of petroleum ether phase, 73.9 g of ethyl acetate phase, 316.7 g of n-butanol phase and 759.3 g of water phase. The ethyl acetate fraction was subjected to forward silica gel chromatography (200-300 mesh) and eluted with a dichloromethane-methanol (100:1-1:1) gradient. The fraction was passed through a forward silica gel plate and eluted with petroleum ether-ethyl acetate 1: 1 is the developing agent, combine the fractions Fr.7 with R f value between 0.3 and 0.8, Fr.7 is subjected to forward silica gel chromatography (100-200 mesh), and dichloromethane-methanol (50:1-1: 1) Gradient elution, the fractions are developed through the forward silica gel plate using dichloromethane-methanol 10:1 as the developing solvent, and the fractions Fr.7.6 with R f value between 0.1 and 0.6 are combined, and the fractions Fr.7.6 are passed through the reversed-phase ODS column. Chromatography, use methanol-water (20:80~100:0) gradient elution, the fractions are developed on a forward silica gel plate using dichloromethane-methanol 10:1 plus 2 drops of formic acid as a developing agent, and the combined R f value is between 0.3~ The fractions Fr.7.6.2 and Fr.7.6.2 between 0.4 and 0.4 were separated by Sephadex LH-20 chromatography (methanol, height: 1.5 meters, flow rate: 4 seconds per drop), and then purified by semi-preparative liquid phase (acetonitrile-water 15:85; volume flow 3 ml/min; detection wavelength: 365 nm), purified compound 4-(1 E )-1-propen-1-ylphenyl β - D -glucopyranoside [trans-4- (1-propenyl)-phenol- β - D -glucopyranoside (9.9 mg)] is p-propenylphenol glycoside. The chemical structure of this compound is shown in Figure 1. Figure 2 is the 1H-NMR spectrum of p-propenylphenol glycoside. Figure 3 is the 13C-NMR (DEPT) spectrum of p-propenylphenol glycoside.
对丙烯基苯酚糖苷的理化常数及波谱数据Physicochemical constants and spectral data of p-propenylphenol glycosides
白色粉末状结晶(甲醇);分子式:C15H20O6 HR-ESI-MS,m/z 319.1152 [M+Na]+(计算值:319.1152)。1H-NMR(400MHz,CD3OD)δ H:6.36(1H,d,J= 15.8Hz,H-7),6.15(1H,dq,J=15.8,6.5Hz,H-8),3.80(6H,m,H-2′,3′,4′,5′,6′),1.85(3H,d,J= 6.6Hz,H-9).13C-NMR(100MHz,CD3OD)δ C:158.1(s,C-4),133.8(s,C-1),131.6(d,C-7),127.8(d,C-2,6),124.8(d,C-8),117.8(d,C-3,5),102.4(d,C-1′),78.1(d,C-3′),77.9(d,C-5′),74.9(d,C-2′),71.4(d,C-4′),62.5(t,C-6′),18.5(q,C-9)。White powdery crystal (methanol); molecular formula: C 15 H 20 O 6 HR-ESI-MS, m/z 319.1152 [M+Na] + (calculated value: 319.1152). 1 H-NMR (400MHz, CD 3 OD) δ H : 6.36 (1H, d, J = 15.8Hz, H-7), 6.15 (1H, dq, J = 15.8, 6.5Hz, H-8), 3.80 ( 6H, m, H-2′, 3′, 4′, 5′, 6′), 1.85 (3H, d, J = 6.6Hz, H-9). 13 C-NMR (100MHz, CD 3 OD) δ C : 158.1 (s, C-4), 133.8 (s, C-1), 131.6 (d, C-7), 127.8 (d, C-2, 6), 124.8 (d, C-8), 117.8 (d, C-3, 5), 102.4 (d, C-1′), 78.1 (d, C-3′), 77.9 (d, C-5′), 74.9 (d, C-2′), 71.4 (d, C-4′), 62.5 (t, C-6′), 18.5 (q, C-9).
实施例3Example 3
抗酪氨酸酶活性的作用研究Study on the role of anti-tyrosinase activity
本方法为参考文献的基础上修改。(Li ZY, Zhao P, Song SJ, Huang XX.Chiral resolution of racemic phenylpropanoids with tyrosinaseinhibitoryactivities from the fruits of Crataegus pinnatifida Bge. J FoodBiochem. 2022 Oct;46(10):e14304.)。This method is modified based on the reference. (Li ZY, Zhao P, Song SJ, Huang XX. Chiral resolution of racemic phenylpropanoids with tyrosinaseinhibitoryactivities from the fruits of Crataegus pinnatifida Bge. J FoodBiochem. 2022 Oct;46(10):e14304.).
1 材料与仪器1 Materials and instruments
1.1 材料1.1 Materials
酪氨酸酶(Sigma-Aldrich公司);L-酪氨酸(上海麦克林生化科技有限公司)β-熊果苷(上海源叶生物科技有限公司)。Tyrosinase (Sigma-Aldrich Company); L-tyrosine (Shanghai McLean Biochemical Technology Co., Ltd.) β -arbutin (Shanghai Yuanye Biotechnology Co., Ltd.).
1.2 仪器1.2 Instruments
Synergy2多功能酶标仪(美国BIOTEK)。Synergy2 multifunctional microplate reader (BIOTEK, USA).
酪氨酸酶抑制活性测试Tyrosinase inhibitory activity test
2.1溶液的配置2.1 Solution configuration
2.1.1磷酸盐缓冲液的配置2.1.1 Configuration of phosphate buffer solution
精密量取20 ml 10×PBS缓冲液,用超纯水稀释至200 ml,最后使用0.2 mol/L氢氧化钠调节pH至规定范围(6.5~7.5)即得PBS缓冲液。Precisely measure 20 ml of 10×PBS buffer, dilute it with ultrapure water to 200 ml, and finally use 0.2 mol/L sodium hydroxide to adjust the pH to the specified range (6.5~7.5) to obtain the PBS buffer.
酪氨酸酶试液的配置Preparation of tyrosinase test solution
精密移取提前分装好的100 units/ml的酪氨酸酶(SLCN1560)9 ml,加入PBS缓冲液稀释至30 ml即得30 units/ml的酪氨酸酶试液,将试液放入-20 ℃冰箱待用。Precisely pipette 9 ml of 100 units/ml tyrosinase (SLCN1560) that has been packed in advance, add PBS buffer and dilute to 30 ml to obtain a 30 units/ml tyrosinase test solution, put the test solution into -20℃ refrigerator until use.
酪氨酸溶液的配置Preparation of tyrosine solution
精密称取5 mg L-酪氨酸(批号:C14856769)粉末于100 ml EP管中加入50 ml PBS缓冲液,摇匀,即得0.1 mg/ml L-酪氨酸溶液,放置,待用。Precisely weigh 5 mg of L-tyrosine (batch number: C14856769) powder into a 100 ml EP tube, add 50 ml of PBS buffer, and shake well to obtain a 0.1 mg/ml L-tyrosine solution. Set aside for use.
样品溶液的配置Sample solution configuration
(1)阳性药溶液的配置(1) Configuration of positive drug solution
精密称取β-熊果苷(批号:T17S6B1)粉末4 mg,加入30 ul DMSO使其完全溶解,再使用移液枪精密加入970 ul PBS即得4 mg/ml阳性药试液,再将阳性药依次梯度稀释浓度为2 mg/ml、1 mg/ml、0.5 mg/ml、0.25 mg/ml,待用。Precisely weigh 4 mg of β -arbutin (batch number: T17S6B1) powder, add 30 ul DMSO to dissolve it completely, and then use a pipette to accurately add 970 ul PBS to obtain a 4 mg/ml positive drug test solution. The gradient dilution concentration of the drug is 2 mg/ml, 1 mg/ml, 0.5 mg/ml, and 0.25 mg/ml, and is ready for use.
(2)待测样品溶液的配置(2) Configuration of sample solution to be tested
精密称取实施例2制备得来的对丙烯基苯酚糖苷适量,加入30 ul DMSO使其完全溶解,再精密加入PBS使其浓度依次为1mg/ml、0.5 mg/ml、0.25 mg/ml、0.125 mg/ml、0.0625 mg/ml,待用。Accurately weigh an appropriate amount of p-propenylphenol glycoside prepared in Example 2, add 30 ul DMSO to completely dissolve it, and then add PBS accurately to make the concentration sequentially 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, and 0.125 mg/ml, 0.0625 mg/ml, set aside.
酪氨酸酶活性抑制率的测定Determination of tyrosinase activity inhibition rate
用移液枪按表1的体积向96孔板依次加入PBS缓冲液、不同浓度梯度的化合物受试液、不同浓度梯度的熊果苷对照液和酪氨酸酶液,37 ℃下孵育10 min后,加入L-酪氨酸试液,同等条件下孵育30 min,孵育完成后立即放入多功能酶标仪在492 nm测定其吸光度,并记录数据,每个浓度实验做3个平行组,使用3组数据的平均值,按照以下公式计算测定化合物对酪氨酸酶的抑制率:Use a pipette to add PBS buffer, compound test solutions with different concentration gradients, arbutin control solutions and tyrosinase solutions with different concentration gradients to the 96-well plate in sequence according to the volumes in Table 1, and incubate at 37°C for 10 minutes. Afterwards, add L-tyrosine test solution and incubate for 30 minutes under the same conditions. After the incubation is completed, immediately put it into a multifunctional microplate reader to measure the absorbance at 492 nm and record the data. Do 3 parallel groups for each concentration experiment. Using the average of the three sets of data, calculate the inhibitory rate of the tested compound on tyrosinase according to the following formula:
抑制率=[1-(AT-AB)/(AC-AN)]×100%Inhibition rate = [1-(A T -A B )/( AC -A N )]×100%
其中,T:为加样品且加酪氨酸的反应液组别;B:为加样品且未加酪氨酸的反应液组别;C:为未加样品且加酪氨酸的反应液组别;N:为未加样品且未加酪氨酸的反应液组别。AT:为T组反应液在492nm处测得的吸光度值;AB:为B组反应液在492nm处测得的吸光度值;AC:为C组反应液在492nm处测得的吸光度值;AN:为N组反应液在492nm处测得的吸光度值。Among them, T: is the reaction solution group with sample and tyrosine added; B: is the reaction solution group with sample and no tyrosine added; C: is the reaction solution group without sample and tyrosine is added. Different; N: is the reaction solution group without adding sample and without adding tyrosine. A T : is the absorbance value measured at 492nm for the reaction solution of group T; A B : is the absorbance value measured at 492nm for the reaction solution of group B; A C : is the absorbance value measured at 492nm for the reaction solution of group C ; A N : is the absorbance value measured at 492nm of the N group reaction solution.
表1 反应液组成Table 1 Reaction solution composition
2.3酪氨酸酶抑制实验结果2.3 Tyrosinase inhibition experimental results
阳性药β-熊果苷对酪氨酸酶活性的浓度抑制结果如图4所示,其抑制率由高到低依次为62.79%;50.24%;41.48%;33.19%;18.73%,其中阳性药对酪氨酸酶抑制率均随着受试液浓度提升而提升,浓度小于1 mg/ml时,阳性药的抑制率随浓度的升高增加得更快,当浓度大于1 mg/ml时,增长得较为缓慢,表现为浓度依赖性抑制,其IC50值为1.784 mg/ml。The concentration inhibition results of the positive drug β -arbutin on tyrosinase activity are shown in Figure 4. The inhibition rates from high to low are 62.79%; 50.24%; 41.48%; 33.19%; 18.73%. Among them, the positive drug The inhibition rate of tyrosinase increases with the concentration of the test solution. When the concentration is less than 1 mg/ml, the inhibition rate of the positive drug increases faster with the increase of concentration. When the concentration is greater than 1 mg/ml, The growth rate is relatively slow, showing concentration-dependent inhibition, and its IC 50 value is 1.784 mg/ml.
化合物对酪氨酸酶活性的浓度抑制结果如图5所示,其抑制率由高到低依次为54.58%;48.83%;42.05%;35.24%;28.24%,其对酪氨酸酶抑制率同样随着受试液浓度提升而提升,化合物浓度在0.5 mg/ml以下时抑制率随浓度增加得较快,当浓度大于0.5 mg/ml时增长速率变得更加缓慢,表现为浓度依赖性抑制,其IC50值为0.575 mg/ml。The concentration inhibition results of the compound on tyrosinase activity are shown in Figure 5. The inhibition rates from high to low are 54.58%; 48.83%; 42.05%; 35.24%; 28.24%. The inhibition rates for tyrosinase are also the same. It increases with the concentration of the test solution. When the compound concentration is below 0.5 mg/ml, the inhibition rate increases rapidly with concentration. When the concentration is greater than 0.5 mg/ml, the growth rate becomes slower, showing concentration-dependent inhibition. Its IC 50 value is 0.575 mg/ml.
结果分析Result analysis
抑制率实验结果显示,化合物浓度为1 mg/ml时对酪氨酸酶的抑制率为54.58%,而阳性药β-熊果苷的抑制率只有41.48%,同时化合物IC50值为0.575 mg/ml,为阳性药β-熊果苷(IC50值为1.784 mg/ml)的三分之一,表明化合物抑制酪氨酸酶的活性远远大于β-熊果苷,具有更好的美白效果。以上结果均表明,化合物对丙烯基苯酚糖苷具有比阳性药更好的美白活性。且该苯丙素类化合物为首次从小茴香中分离得到,具有较好的研究前景。The results of the inhibition rate experiment showed that when the compound concentration was 1 mg/ml, the inhibition rate of tyrosinase was 54.58%, while the inhibition rate of the positive drug β -arbutin was only 41.48%, and the compound IC 50 value was 0.575 mg/ml. ml, which is one-third of the positive drug β -arbutin (IC 50 value is 1.784 mg/ml), indicating that the compound’s tyrosinase inhibitory activity is much greater than β -arbutin and has a better whitening effect. . The above results all show that the compound p-propenylphenol glycoside has better whitening activity than the positive drug. This phenylpropanoid compound is isolated from cumin for the first time and has good research prospects.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310888639.7A CN116589515B (en) | 2023-07-19 | 2023-07-19 | Preparation method of p-propenylphenol glycoside with whitening effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310888639.7A CN116589515B (en) | 2023-07-19 | 2023-07-19 | Preparation method of p-propenylphenol glycoside with whitening effect |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116589515A CN116589515A (en) | 2023-08-15 |
CN116589515B true CN116589515B (en) | 2023-09-19 |
Family
ID=87594217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310888639.7A Active CN116589515B (en) | 2023-07-19 | 2023-07-19 | Preparation method of p-propenylphenol glycoside with whitening effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116589515B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145775A (en) * | 2013-01-22 | 2013-06-12 | 广西壮族自治区中医药研究院 | Preparation and quality control method for high purity cleidion brevipetiolatum glycoside A |
CN104212228A (en) * | 2014-09-22 | 2014-12-17 | 句容市给力包装制品厂 | High-adhesion ink for external package and preparation method thereof |
CN105348333A (en) * | 2015-11-18 | 2016-02-24 | 浙江大学 | Allyl phenol bioside compound and preparation method and application thereof |
CN110615821A (en) * | 2019-09-17 | 2019-12-27 | 西北大学 | Mulberry extract, extraction and separation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3098715B1 (en) * | 2019-07-19 | 2021-12-31 | Laboratoire Garancia | Skin whitening cosmetic composition comprising hexylresorcinol, undecylenoyl phenylalanine and trimethoxybenzylidene pentanedione. |
-
2023
- 2023-07-19 CN CN202310888639.7A patent/CN116589515B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103145775A (en) * | 2013-01-22 | 2013-06-12 | 广西壮族自治区中医药研究院 | Preparation and quality control method for high purity cleidion brevipetiolatum glycoside A |
CN104212228A (en) * | 2014-09-22 | 2014-12-17 | 句容市给力包装制品厂 | High-adhesion ink for external package and preparation method thereof |
CN105348333A (en) * | 2015-11-18 | 2016-02-24 | 浙江大学 | Allyl phenol bioside compound and preparation method and application thereof |
CN110615821A (en) * | 2019-09-17 | 2019-12-27 | 西北大学 | Mulberry extract, extraction and separation method and application thereof |
Non-Patent Citations (2)
Title |
---|
"Phenylpropanoids from Strophioblachia fimbricalyx and their chemotaxonomical significance";Changshui Yang,et al;《 Biochemical Systematics and ecology》;第2页。 * |
"天然二苯乙基类化合物的结构、来源及药理活性研究进展";字成庭,等。;《广州化工》;第第48卷卷(第第9期期);第40-49页。 * |
Also Published As
Publication number | Publication date |
---|---|
CN116589515A (en) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Phenolics from Bidens bipinnata and their amylase inhibitory properties | |
Zhang et al. | α-Glucosidase inhibitors from Chinese yam (Dioscorea opposita Thunb.) | |
CN106916193B (en) | A method of extracting afzclin from cercis leaf | |
CN106674311A (en) | Benzofuran glycoside compounds as well as preparation method and application thereof | |
CN114146083B (en) | Sophora japonica extract and active ingredient and application thereof in preparation of products for treating glycolipid metabolism comprehensive disorder | |
CN112608295A (en) | Large-leaf hematinic amide lignan compound and preparation method and application thereof | |
CN116606273B (en) | Preparation method of oleander flavone with whitening effect | |
Qin et al. | Choushenosides AC, three dimeric catechin glucosides from Codonopsis pilosula collected in Yunnan province, China | |
CN116589515B (en) | Preparation method of p-propenylphenol glycoside with whitening effect | |
CN112358516B (en) | Application of a geranin (4-O-methyl) glucoside compound in the preparation of lipid-lowering drugs | |
CN109497506A (en) | A kind of acrylamide natural inhibitor | |
CN108997296A (en) | The structure and purposes of several isopentene group dihydro Stilbene and isoamylene radical chromocor | |
CN104447656B (en) | A kind of Leaf and twig of Common Jasminorange tonka bean camphor and extracting method thereof | |
CN108948038B (en) | A new pterane-type flavonoid compound and use thereof | |
CN106565444B (en) | The extracting method and application of Chinese yam aerial part phenanthrene class compound | |
CN114835668B (en) | Preparation method and application of a cyclic ether type diarylheptane in Qinglongyi | |
CN102772501A (en) | Rheum emodi Wall. extract and its preparing method | |
CN113004299B (en) | Xanthone compound in mangosteen bark for reducing postprandial blood sugar, and extraction method and application thereof | |
CN107501367A (en) | The O β D glucuronic acids butyl esters of chrysoeriol 7 and its extracting method and purposes | |
CN103739660B (en) | A kind of compound, its extracting method, its application preparing antitumor drug and antitumor drug of preparation thereof | |
CN107446009A (en) | The O β D glucuronic acid methyl esters of chrysoeriol 7 and its extracting method and purposes | |
CN109053673B (en) | Sesquilignan compound, preparation method and application thereof | |
CN105399784B (en) | A kind of new Phenylpropanoid Glycosides glycosides compound and its production and use | |
CN114736251B (en) | Extraction monomer chrysanthemum B from golden chrysanthemum and its extraction method and application | |
CN113354539B (en) | Morinda officinalis iridoid compound with anti-inflammatory activity and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231229 Address after: Room 12, 2nd Floor, Building 3, No. 39 Jiatai Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, 200000 Patentee after: Shanghai Haibeilizhi Cosmetics Co.,Ltd. Address before: No.1076, Yuhua Road, Chenggong District, Kunming, Yunnan 650500 Patentee before: Yunnan University of Traditional Chinese Medicine |